Protalix Biotherapeutics Stock Target Price and Analyst Consensus
| PLX Stock | USD 2.90 0.02 0.68% |
The current analyst and expert consensus on Protalix Biotherapeutics is Buy, with no strong buy opinions. The current projected Protalix Biotherapeutics target price consensus is 11.00 with 1 analyst opinions. Check out Macroaxis Advice on Protalix Biotherapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Protalix Stock please use our How to Invest in Protalix Biotherapeutics guide.The most common way Protalix Biotherapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Protalix Biotherapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Protalix Biotherapeutics. We encourage you to use your own analysis of Protalix Biotherapeutics to validate this analysis. Protalix Biotherapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Protalix Biotherapeutics target price to derive its highest and lowest estimates based on projected price volatility of 3.7488.
Lowest Forecast 10.01 | Highest Forecast 12.21 | Target Price 11 |
It's important to approach Protalix Biotherapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Protalix Biotherapeutics Target Price Consensus
Protalix target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Protalix Biotherapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Buy |
Most Protalix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Protalix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Protalix Biotherapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationProtalix Biotherapeutics Target Price Projection
Protalix Biotherapeutics' current and average target prices are 2.90 and 11.00, respectively. The current price of Protalix Biotherapeutics is the price at which Protalix Biotherapeutics is currently trading. On the other hand, Protalix Biotherapeutics' target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Protalix Biotherapeutics Market Quote on 12th of February 2026
Target Price
Analyst Consensus On Protalix Biotherapeutics Target Price
Protalix Biotherapeutics Analyst Ratings
Protalix Biotherapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Protalix Biotherapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Protalix Biotherapeutics' financials, market performance, and future outlook by experienced professionals. Protalix Biotherapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Protalix Biotherapeutics price targets
Protalix Biotherapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Protalix Biotherapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Protalix Biotherapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Protalix Biotherapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Protalix Biotherapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Protalix Biotherapeutics is a key component of Protalix Biotherapeutics valuation and have some predictive power on the future returns of a Protalix Biotherapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | SRI Sustainable Growth Invested over 90 shares | |
 | ESG Investing Sold few shares | |
 | Millennials Best Invested over 90 shares | |
Additional Tools for Protalix Stock Analysis
When running Protalix Biotherapeutics' price analysis, check to measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.